Beginning Cash: The amount of cash reported by the company on its previous statement.
Oric Pharmaceuticals, Inc. (ORIC) had Beginning Cash of $23.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-127.85M |
|
-- |
|
-- |
|
$142.90M |
|
$-142.90M |
|
$15.05M |
|
$-127.85M |
|
$-127.85M |
|
$-127.85M |
|
$-127.85M |
|
$-127.85M |
|
$-127.85M |
|
$-142.90M |
|
$-149.89M |
|
69.73M |
|
69.73M |
|
$-1.83 |
|
$-1.83 |
|
| Balance Sheet Financials | |
$262.25M |
|
$2.92M |
|
$11.89M |
|
$274.14M |
|
$24.85M |
|
-- |
|
$6.17M |
|
$31.02M |
|
$243.12M |
|
$243.12M |
|
$243.12M |
|
71.02M |
|
| Cash Flow Statement Financials | |
$-112.66M |
|
$22.14M |
|
$126.55M |
|
|
Beginning Cash |
$23.88M |
$59.90M |
|
$36.02M |
|
$20.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-113.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.59% |
|
-52.59% |
|
-46.64% |
|
-52.59% |
|
$3.42 |
|
$-1.63 |
|
$-1.62 |
|